Clinical significance of P-glycoprotein in multidrug resistance malignancies.

scientific article

Clinical significance of P-glycoprotein in multidrug resistance malignancies. is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232
review articleQ7318358

External links are
P698PubMed publication ID8097632

P2093author name stringArceci RJ
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectmultiple drug resistanceQ643839
P304page(s)2215-2222
P577publication date1993-05-01
P1433published inBloodQ885070
P1476titleClinical significance of P-glycoprotein in multidrug resistance malignancies
P478volume81

Reverse relations

cites work (P2860)
Q34770077An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells
Q54443441Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population.
Q35828737Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease
Q42319809CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? -inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration
Q36291762Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas
Q42999081Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression
Q33814552Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.
Q41482189Effect of cyclosporin on distribution of methotrexate into the brain of rats
Q50267725Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia
Q60936453Genetic and molecular origins of colorectal Cancer among the Iranians: an update
Q64937855Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid.
Q40522075Important issues in high dose chemotherapy and stem cell transplantation
Q71170983In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma
Q33758413Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)
Q40972927Molecular biology of leukemia for the clinician
Q36184500Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase
Q39369429Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment
Q72261484Multidrug resistance in human cancer
Q36722841N-(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia
Q37763152Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
Q37263676P-glycoprotein positive, drug resistant invasive lymphoepithelial thymoma: treatment response to chemotherapy with cyclosporin and quinine
Q40630952P-glycoprotein, multidrug resistance and tumor progression
Q52908251Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors.
Q33729158Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group
Q39998933Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein
Q34446806Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.
Q40658770Some aspects of cancer medicine
Q24522515The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein
Q38738159The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis
Q39580341The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line
Q40696534Treatment options--commentary
Q43781828Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.

Search more.